Delapril Hydrochloride

The hydrochloride salt of delapril, a lipophilic, non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Les effets benefiques des inhibiteurs de l’enzyme de conversion de l’angiotensine (IEC) sur la mortalite, la morbidite et la… Expand
Is this relevant?
2003
2003
OBJECTIVE The objective of the study was to assess potential pharmacokinetic interactions between delapril, an angiotensin… Expand
Is this relevant?
2003
2003
Long-term treatment with an angiotensin II type 1 receptor blocker (ARB) has been shown to decrease the plasma renin activity… Expand
Is this relevant?
2003
2003
OBJECTIVES The aim of the present study was to compare the pharmacokinetic and pharmacodynamic properties of a fixed combination… Expand
Is this relevant?
2000
2000
Thirty-nine hypertensive patients with type 2 diabetes mellitus were followed under long-term treatment (mean, 20.7 months) with… Expand
Is this relevant?
1998
1998
The long-term effect of delapril hydrochloride, a non-sulfhydryl angiotensin converting enzyme inhibitor, on serum concentrations… Expand
Is this relevant?
1994
1994
An oral controlled-release drug delivery system based on microspheres of polyglycerol esters of fatty acids (PGEFs), was applied… Expand
Is this relevant?
1994
1994
OBJECTIVE To investigate the effects of long term treatment with delapril hydrochloride (an angiotensin-converting enzyme… Expand
Is this relevant?
1992
1992
To study the effect of antihypertensive therapy on the regulation of renin gene expression, the levels of tissue renin messenger… Expand
Is this relevant?
1987
1987
The acute effect on the renin-angiotensin system and the pharmacokinetic properties of delapril, a new angiotensin converting… Expand
Is this relevant?